Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Hormone Therapy and Angiotensin-Dependent Arterial and Renal

NCT05442463 is registered in ClinicalTrials.gov with University of Calgary as lead sponsor.

NCT NCT05442463
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05442463 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Hormone Therapy and Angiotensin-Dependent Arterial and Renal
Lead sponsor
University of Calgary
Phase
Observational
Overall status
Recruiting
Start date
November 30, 2020
Completion date
November 30, 2025
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hormone therapy